Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors
Published 11 May 2020 Heparin is the preferred choice of anticoagulant in percutaneous coronary intervention (PCI) for acute myocardial infarction (MI). An established dosage of heparin has not yet been determined, but treatment may be optimized through monitoring of activated clotting time (ACT).. New publication in Europe PMC